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degradation, suggesting that integrins
also regulate localized degradation of
the BM (Hagedorn et al., 2009). Future
studies utilizing mammalian systems
with greater integrin signaling complexity
are now needed to build on and refine
the current model, and, hopefully, to
bridge the gap between mechanisms
regulating controlled invasion during de-
velopment and the complex signaling net-
works promoting humandiseases such as
cancer.
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The transcription factor BLIMP1 is a master regulator of primordial germ cell (PGC) specification and is
suppressed by the microRNA let-7. In a recent issue of Nature, West and colleagues use a unique in vitro
ES cell differentiation strategy to show that LIN28 is an essential regulator of PGC formation through inhibi-
tion of let-7 maturation and consequential induction of BLIMP1.PGCs are the first cells in the mouse
embryo to become committed to a spe-
cific fate. Cells in the early mouse embryo
are pluripotent, but a transition occurs
around embryonic day (E) 5.5–6.0 when
signaling bybonemorphogenetic proteins
(BMP2, BMP4, and BMP8B) induces
proximal epiblast cells to adopt a PGC
fate. At about E6.25–6.5 founder PGCs
emerge (Figure 1A), and by E7.5 about
40 PGCs can be identified by the expres-
sion of PGC-specific markers.
Identifying the factors required for PGC
specification in the embryo has been chal-
lenging and so far only a few factors have
been found. Early studieswere rather labo-
rious, relying on differential expression
analyses, comparing gene expression in
PGC and non-PGC cells, followed by
gene knockout studies. These studies
nevertheless were able to identify some
important PGC regulators such as
PRDM14 ([PRDI-BF1-RIZ]/SET domain
containing 14) and BLIMP1 (B-Lympho-
cyte-induced maturation protein1, also
known as PRDM1), which are expressed160 Developmental Cell 17, August 18, 2009in PGCs starting at the founder stage and
are essential for PGC specification (Ohi-
nata, et al., 2005; Vincent, et al., 2005;
Yamaji, et al., 2008). Two other proteins,
TNAP (tissue nonspecific alkaline phos-
phatase) and STELLA (also known as
DPPA3,developmentalpluripotency-asso-
ciated 3), are also expressed specifically in
PGCs, starting atE7.5,but are not essential
for PGC formation. West et al. (2009) build
on this previouswork to create,manipulate
and study PGCs outside of the embryo,
leading to the identification of LIN28 as
a third major player in PGC specification.
To identify PGCs in vitro, West et al.
(2009) and Wei et al. (2008) took advan-
tage of 100% concordance of PGCs and
STELLA expression. They created mouse
ES cells that contain Stella-GFP reporter
constructs. They then manipulated the
cells (by formation of embryoid bodies)
and found a small population that
expressed GFP, indicating that founder
PGCs were forming in vitro, and that the
Stella-GFP constructs were working as
expected (Figure 1B). West et al. (2009)ª2009 Elsevier Inc.were then able to identify PGC specifica-
tion genes by testing the effects of lenti-
virus-delivered shRNA knockdown of
30 candidate genes, selected based on
previous differential expression in PGCs
versus somatic cells. Because TNAP
more precisely marks true PGCs in vitro,
the authors used formation of TNAP-posi-
tive colonies as their assays for the effects
of each knockdown. As expected, knock-
down of Blimp1 dramatically reduced
the number of TNAP-positive colonies.
Equally effectivewasknockdownofLin28,
an evolutionarily conserved gene that was
recently shown to play key roles in ES
differentiation. Along with the three tran-
scription factors, OCT4, SOX2, and
NANOG, the RNA-binding protein LIN28
can reprogram human fibroblasts into
induced pluripotent stem (iPS) cells that
resemble humanES cells (Yu, et al., 2007).
Several recent studies are now starting
to shed light on the mechanism by which
LIN28 functions in ES and other cells.
During microRNA biosynthesis, a primary
miRNA (pri-miRNA) is processed to a
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Previewsprecursor miRNA (pre-miRNA) and
eventually to a mature microRNA
(miRNA) that functions to modulate
mRNAstability and protein translation.
Surprisingly, mouse and human ES
cells have very high levels of pri-miR-
NAs, yet the levels of processed miR-
NAs are not always as high. In partic-
ular, there is a dramatic block in the
processingof the abundant and evolu-
tionarily-conserved let-7 family pri-
miRNAs tomaturemiRNAs (Thomson,
et al., 2006). Last year, four groups
discovered independently that LIN28
and its paralog LIN28Bare key players
in let-7 processing, acting by binding
to the let-7 pre-miRNA and pri-miRNA
and altering their processing or
stability (reviewed in Bussing et al.,
2008; Figure 1C). In a separate study,
and in a different context, Nie, et al.,
(2008) discovered an association
between BLIMP1 and let-7a in Hodg-
kin’s lymphoma, a type of cancer
involving abnormal B cells (i.e., Reed-
Sternberg cells). BLIMP1 is a master
regulator of B cell differentiation as
well. In Reed-Sternberg cells, let-7a is
highly expressed whereas BLIMP1 is
suppressed. Nie et al. (2008) then
showed that the let-7a miRNA bound
to a target sites in the BLIMP1 30 UTR
to suppress BLIMP1 expression.
Together these studies suggest that
LIN28 and LIN28B suppress let-7
synthesis in ES cells and likely also
during formation of iPS cells, whereas let-
7 suppresses BLIMP1 in lymphoma cells.
The work of West et al. (2009) now
connects all of these players in PGCs.
Since knockdown of LIN28 or LIN28B in
the Stella-GFP ES cells by West and
colleagues resulted in fewer TNAP-posi-
tive colonies, the authors postulated that
LIN28andLIN28Bcouldbeacting through
let-7 to suppress BLIMP1 expression.
Indeed, expression of a Blimp1 construct
lacking the let-7 binding site in the Blimp1
30 UTR overrode the block in formation of
PGCs caused by LIN28 or LIN28B knock-
down. Furthermore, overexpression of
Lin28 induced more TNAP-positive PGCs
expressing the correct repertoire of PGC
markers (e.g., Prdm14). These findings
not only confirm the requirement for
LIN28 and BLIMP1 in PGC formation, but
also demonstrate for the first time that
suppression of miRNA biosynthesis is
critical for PGC specification (Figure 1C).
Several questions arise from the above
studies. Is LIN28 expressed continuously
in ES cells through formation of PGCs?
Since BMPs play such critical permissive
roles in the formation of PGC precursors,
do they directly regulate LIN28 expression?
Would transient suppression of LIN28 in
PGCsbeuseful fordedifferentiating thecells
intopluripotentEScells?Thesestudiesmay
also have implications in the field of repro-
duction. Because overexpression of LIN28
in mouse ES cells is an effective way to
direct the cells toward a PGC fate, it may
be possible to discover additional genes
required during PGC specification as well
as downstream genes that can cause the
PGCs to fully differentiate into fertilizable
male or female germ cells. For example,
sequential expression of stage-specific
reporters may make it easier to identify
growth conditions and gene products
required for completion of oogenesis and
spermatogenesis. Ultimately, the results of
suchstudiescouldbeapplied tohuman
ES cells to generate a ready supply of
human oocytes and spermatozoa.
Besides their roles in the germline,
Daley’s laboratory also implicates
LIN28 and LIN28B as major players in
cancer. While the West et al. (2009)
study demonstrated that multiple
human testicular germ cell tumors
express these proteins, Viswanathan,
et al., (2009) showed that 15% of
cancers overexpress LIN28 and/or
LIN28Bandrepress let-7. Furthermore,
during key developmental junctures,
LIN28 is also a target of let-7, resulting
in an important feedback to downregu-
late LIN28. Although it is unknown
whether overexpression of LIN28 is
a driver or a passenger in BLIMP1-
mediated oncogenesis and other
cancers, the recent studies implicate
LIN28 andLIN28Bas important control
proteins, low levels of which may
dictate a ‘‘good year’’ for the patient.
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Figure 1. PGC Specification and Interactions of
LIN28, let-7, and BLIMP1
(A) Mouse ES cells (yellow), derived from E3.5 blastocysts,
are pluripotent. At E6.5, the founder population of PGCs
(green), the first cells in the embryo to commit to a particular
fate, forms from epiblast cells (yellow) in the posterior (pos)
but not the anterior (ant) part of the embryo.
(B) The Stella-GFP transgene is dormant in ES cells, but is
transcriptional active when the ES cells are allowed to
differentiate into PGCs in vitro.
(C) In the absence of LIN28, let-7 will bind to the 30UTR of
the BLIMP1 mRNA to block its translation and prevent
PGCs from developing (left). During PGC formation, LIN28
binds to the let-7 family pri-miRNA/pre-miRNA loop to
prevent processing of these precursor forms into the
mature let-7 miRNA, allowing BLIMP1 translation, and
permitting PGC specification (right).Developmental Cell 17, August 18, 2009 ª2009 Elsevier Inc. 161
